St. Michael's Hospital, University of Toronto, and ICES, Toronto, Ontario, Canada (J.G.R.).
Sunnybrook Research Institute, University of Toronto, and ICES, Toronto, Ontario, Canada (M.J.S.).
Ann Intern Med. 2021 Mar;174(3):308-315. doi: 10.7326/M20-4511. Epub 2020 Nov 24.
The ABO and rhesus (Rh) blood groups may influence risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
To determine whether ABO and Rh blood groups are associated with risk for SARS-CoV-2 infection and severe coronavirus disease 2019 (COVID-19) illness.
Population-based cohort study.
Ontario, Canada.
All adults and children who had ABO blood group assessed between January 2007 and December 2019 and who subsequently had SARS-CoV-2 testing between 15 January and 30 June 2020.
The main study outcome was SARS-CoV-2 infection, determined by viral RNA polymerase chain reaction testing. A second outcome was severe COVID-19 illness or death. Adjusted relative risks (aRRs) and absolute risk differences (ARDs) were adjusted for demographic characteristics and comorbidities.
A total of 225 556 persons were included, with a mean age of 54 years. The aRR of SARS-CoV-2 infection for O blood group versus A, AB, and B blood groups together was 0.88 (95% CI, 0.84 to 0.92; ARD, -3.9 per 1000 [CI, -5.4 to -2.5]). Rhesus-negative (Rh-) blood type was protective against SARS-CoV-2 infection (aRR, 0.79 [CI, 0.73 to 0.85]; ARD, -6.8 per 1000 [CI, -8.9 to -4.7]), especially for those who were O-negative (O-) (aRR, 0.74 [CI, 0.66 to 0.83]; ARD, -8.2 per 1000 [CI, -10.8 to -5.3]). There was also a lower risk for severe COVID-19 illness or death associated with type O blood group versus all others (aRR, 0.87 [CI, 0.78 to 0.97]; ARD, -0.8 per 1000 [CI, -1.4 to -0.2]) and with Rh- versus Rh-positive (aRR, 0.82 [CI, 0.68 to 0.96]; ARD, -1.1 per 1000 [CI, -2.0 to -0.2]).
Persons who rapidly died of severe COVID-19 illness may not have had SARS-CoV-2 testing.
The O and Rh- blood groups may be associated with a slightly lower risk for SARS-CoV-2 infection and severe COVID-19 illness.
Ontario Academic Health Sciences Centre AFP Innovation Fund and the Ontario Ministry of Health and Long-Term Care.
ABO 和 Rh(恒河猴)血型可能会影响严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的风险。
确定 ABO 和 Rh 血型是否与 SARS-CoV-2 感染和严重 2019 年冠状病毒病(COVID-19)疾病的风险相关。
基于人群的队列研究。
加拿大安大略省。
所有在 2007 年 1 月至 2019 年 12 月期间评估 ABO 血型且随后在 2020 年 1 月 15 日至 6 月 30 日期间接受 SARS-CoV-2 检测的成年人和儿童。
主要研究结果是 SARS-CoV-2 感染,通过病毒 RNA 聚合酶链反应检测确定。第二个结果是严重 COVID-19 疾病或死亡。调整后的相对风险(aRR)和绝对风险差异(ARD)是根据人口统计学特征和合并症进行调整的。
共纳入 225556 人,平均年龄为 54 岁。与 A、AB 和 B 血型组合相比,O 血型感染 SARS-CoV-2 的 aRR 为 0.88(95%CI,0.84 至 0.92;ARD,每 1000 人减少 3.9 例[CI,5.4 至 2.5])。Rh-(Rh-)血型对 SARS-CoV-2 感染具有保护作用(aRR,0.79[CI,0.73 至 0.85];ARD,每 1000 人减少 6.8 例[CI,8.9 至 4.7]),尤其是 O-(O-)的人(aRR,0.74[CI,0.66 至 0.83];ARD,每 1000 人减少 8.2 例[CI,10.8 至 5.3])。与其他血型相比,O 型血的人患严重 COVID-19 疾病或死亡的风险也较低(aRR,0.87[CI,0.78 至 0.97];ARD,每 1000 人减少 0.8 例[CI,1.4 至 0.2]),Rh- 与 Rh-(aRR,0.82[CI,0.68 至 0.96];ARD,每 1000 人减少 1.1 例[CI,2.0 至 0.2])。
因严重 COVID-19 疾病而迅速死亡的患者可能未接受 SARS-CoV-2 检测。
O 型和 Rh- 血型可能与 SARS-CoV-2 感染和严重 COVID-19 疾病的风险略低相关。
安大略省学术卫生科学中心 AFP 创新基金和安大略省卫生部和长期护理部。